Skip to main content

Apexigen, Inc.

APGNDelisted Aug 23, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001814140

Apexigen, Inc. was delisted on Aug 23, 2023; its insiders filed their last Form 4 on Aug 25, 2023; 17 institutions reported holding it in 13F filings for Q2 2023, worth $1.37M in total; no superinvestor held it.

Q1 2023 vs. Q4 2022

How the institutions holding Apexigen, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of APGN: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders1520+5
Shares3.16M3.37M+201.6K (+6.4%)
Value$2.16M$1.64M−$516.3K (−23.9%)

New holders (7)

Institutions that held Apexigen, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to APGN in Q1 2023
InstitutionSharesValue% of portfolio
CVI Holdings, LLC150,000$75.0K0.03%
Two Sigma Investments, LP28,970$14.1K0.00%
Two Sigma Securities, LLC28,122$13.7K0.00%
Millennium Management LLC21,771$11.0K0.00%
Renaissance Technologies LLC14,812$7.00K0.00%
Simplex Trading, LLC1,028$00.00%
Cutler Group LP800$00.00%

Sold out (2)

Institutions that held Apexigen, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of APGN in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Citadel Advisors LLC25,624$17.7K
Jane Street Group, LLC17,799$12.1K